
Carmell Corporation - Warrant
Share · US1429221112 · CTCXW (XNAS)
No Price
n/a
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
- | - | 0,00 % | 7,23 % | -34,07 % | -70,33 % | -93,49 % |
Company Profile for Carmell Corporation - Warrant Share
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
Company Data
Name Carmell Corporation - Warrant
Company Carmell Therapeutics Corporation
Symbol CTCXW
Website
https://www.carmellrx.com
Primary Exchange
NASDAQ

ISIN US1429221112
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Rajiv Sarman Shukla
Country United States of America
Currency USD
Employees 0,0 T
Address 2403 Sidney Street, 15203 Pittsburgh
ID Changes
Date | From | To |
---|---|---|
17.07.2023 | ALPAW | CTCXW |
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | CTCXW |
More Shares
Investors who Carmell Corporation - Warrant hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.